Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Claritev (CTEV) EBITDA (2019 - 2025)

Claritev (CTEV) has 6 years of EBITDA data on record, last reported at -$51.8 million in Q4 2025.

  • For Q4 2025, EBITDA rose 60.31% year-over-year to -$51.8 million; the TTM value through Dec 2025 reached -$567.0 million, up 9.53%, while the annual FY2025 figure was -$283.4 million, 82.71% up from the prior year.
  • EBITDA reached -$51.8 million in Q4 2025 per CTEV's latest filing, up from -$69.0 million in the prior quarter.
  • Across five years, EBITDA topped out at $78.2 million in Q3 2021 and bottomed at -$315.6 million in Q3 2024.
  • Average EBITDA over 5 years is -$43.7 million, with a median of $209000.0 recorded in 2023.
  • Peak YoY movement for EBITDA: surged 1868.58% in 2021, then plummeted 99.52% in 2023.
  • A 5-year view of EBITDA shows it stood at $24.9 million in 2021, then decreased by 20.86% to $19.7 million in 2022, then plummeted by 1015.59% to -$180.7 million in 2023, then grew by 27.74% to -$130.6 million in 2024, then soared by 60.31% to -$51.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were -$51.8 million in Q4 2025, -$69.0 million in Q3 2025, and -$130.6 million in Q4 2024.